Form 4 for MRNA Moderna
Accepted 2022-11-08 00:00:00 ET · period of report 2022-11-04 · accession 0001127602-22-025107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-08 | 2022-11-04 | MRNA | Burton Paul | Chief Medical Off | M - OptEx | $0.00 | +402 | 1,146 | +54% | $0 |
| D | 2022-11-08 | 2022-11-07 | MRNA | Burton Paul | Chief Medical Off | S - Sale+OE | $158.68 | -192 | 954 | -17% | -$30.5K |
| D | 2022-11-08 | 2022-11-04 | MRNA | Burton Paul | Chief Medical Off | M - OptEx | $0.00 | -402 | 4,427 | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-04 | M | A | 402 | $0.00 | 1,146 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-07 | S | D | 192 | $158.68 | 954 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-11-04 | M | D | 402 | $0.00 | 4,427 | D | $0.00 · 2022-08-05 to — | 402 Common Stock | (F3) 25% of the shares subject to this restricted stock unit award vested on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |